Foresite Capital Management V, LLC
CIK
1792206
Location
WEST HOLLYWOOD, CA
Portfolio Value
Small
$270,996,707
Diversification
Highly concentrated
Filing Date
Global Rank
#3,266
/ 8,232
▲ 1286
Top Industry
Biotechnology
94.3%
3Y Alpha vs SPY
+31.8%
Period ended 2 months ago
Filed May 15, 2026 · 30d
22 quarters · since Dec 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+255.5%
SPY
+76.3%
Annualised alpha
+31.8%
Max drawdown
−39.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
9 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
47.9%
+13.6 pts
Top 5
92.6%
+0.2 pts
Top 10
100.0%
0.0 pts
HHI
3,082
Highly concentrated+852
Portfolio Trend
22 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $270,996,707 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | −60,386 | 25,905 | $773,264 | |
| No positions match the current search. | |||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NTRA | Natera, Inc. | 67,356 | $15,430,586 | |
| No positions match the current search. | ||||
9 positions ·
$270,996,707 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ALMS |
Alumis Inc.
Healthcare
|
Added | 5,896,995 | $129,910,799 | 47.94% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Held | 1,004,050 | $67,954,104 | 25.08% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 374,069 | $23,917,971 | 8.83% | |
| HIMS |
Hims & Hers Health, Inc.
Healthcare
|
Added | 738,151 | $15,324,014 | 5.65% | |
| EIKN |
Eikon Therapeutics, Inc.
Healthcare
|
NEW | 1,318,983 | $13,954,840 | 5.15% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
Held | 477,078 | $9,570,184 | 3.53% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
NEW | 194,125 | $5,484,031 | 2.02% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
NEW | 265,000 | $4,107,500 | 1.52% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Reduced | 25,905 | $773,264 | 0.29% |